How malignant cells in patients with CLL escape T-cell recognition

Early results from new PD-1 targeted immune therapy

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer

Molecular characterisation of breast cancer: the mutational landscape

Criteria required before implementation of whole genome arrays in clinical practice

Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer

Mouse models of metastatic breast cancer

A pregnancy pill to prevent breast cancer?

Bevacizumab improves PFS in HER-2-positive breast cancer

Use of neutrophils to prevent lung metastases in breast cancer patients

Anaemia management update: blood transfusion and ESA use in oncology

Novel agents and proteasome inhibitors in myeloma